Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group.

MLA

Miravitlles, Marc, et al. “Assessment and Monitoring of Lung Disease in Patients with Severe Alpha 1 Antitrypsin Deficiency: A European Delphi Consensus of the EARCO Group.” Respiratory Research, vol. 25, no. 1, Aug. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12931-024-02929-5.

APA

Miravitlles, M., Turner, A. M., Sucena, M., Mornex, J.-F., Greulich, T., Wencker, M., & McElvaney, N. G. (2024). Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group. Respiratory Research, 25(1), 1–13. https://doi.org/10.1186/s12931-024-02929-5

Chicago

Miravitlles, Marc, Alice M. Turner, Maria Sucena, Jean-François Mornex, Timm Greulich, Marion Wencker, and N. Gerard McElvaney. 2024. “Assessment and Monitoring of Lung Disease in Patients with Severe Alpha 1 Antitrypsin Deficiency: A European Delphi Consensus of the EARCO Group.” Respiratory Research 25 (1): 1–13. doi:10.1186/s12931-024-02929-5.